Browsing tag

drugs

Lipid-Lowering Effect of Renagel

This has been known for awhile, but it is worth repeating–sevelamer (Renagel), in addition to its ability to act as a phosphate binder, also results in LDL cholesterol-lowering effects. Two of the early articles (a 1998 Clinical Nephrology…

1632 2

Use of Hypoglycemic Agents in CKD

Maintaining adequate glycemic control in patients with diabetic kidney disease can be a challenge.  First, it is hypothesized that worsened glycemic control will lead to a greater tendency towards diabetic nephropathy.  Second, individuals with more advanced CKD are…

1588 0

cyclosporine versus tacrolimus

The two calcineurin inhibitors routinely used for kidney transplant immunosuppression are cyclosporine (CSA) and tacrolimus (TAC).  Their mechanism of action is somewhat similar (they both inhibit calcineurin, which under normal circumstances induces transcription of IL-2 in lymphocytes) but…

1989 0

Rapamycin for ADPKD?

Another potentially useful drug to prevent cyst growth in autosomal dominant polycystic kidney disease comes from the interesting observation that kidney transplant patients with native ADPKD kidneys who were given an immunosuppressant regimen containing the drug rapamycin (sirolimus)…

1669 0

Potassium-Sparing Diuretics

The potassium-sparing diuretics consist of the following 4 medications–only some of which (spironolactone & eplerenone in the list below) are structurally similar.   Spironolactone is an antagonist of the aldosterone receptor, which like other steroid receptors is an…

5091 0

Big Pharma Nephrology

The following is a list of major pharmaceutical companies, ranked by total revenue. The numbers are staggeringly high. #1 overall is Johnson & Johnson ($ 63,747,000,000 in 2008 total revenue), followed by Pfizer and Bayer. A few of…

5241 0
Load more